Arrowhead Pharmaceuticals, Inc. ARWR Stock Forecast
AI-powered price prediction and analysis for Arrowhead Pharmaceuticals, Inc. ยท Updated Sept. 25, 2026
See ARWR's Exact Price Target
Create a free account and follow this stock to unlock its full AI forecast โ 3 stocks free.
Sign Up Free with GooglePrice Chart
Key Statistics
About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. (ARWR) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry.
Latest News
Where ARWR sits on the market map
Pharmaceutical Preparations Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | Ticker | AI Signal | Market Cap | P/E |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. | ARWR | โโ% | $9.31B | -x |
| Eli Lilly & โฆ | LLY | โโ% | $1.11T | 41.7x |
| Johnson & Johnson | JNJ | โโ% | $653.61B | 31.1x |
| Beone Medicines Ltd. | ONC | โโ% | $533.38B | -x |
| Abbvie Inc. | ABBV | โโ% | $468.50B | 74.3x |
| Merck & Co., โฆ | MRK | โโ% | $367.07B | 115.7x |
| Novartis Ag | NVS | โโ% | $277.56B | -x |
| Gsk Plc | GSK | โโ% | $212.49B | -x |
| Abbott Laboratories | ABT | โโ% | $176.04B | 28.6x |
| Pfizer Inc | PFE | โโ% | $163.41B | 37.7x |
| Vertex Pharmaceuticals Inc โฆ | VRTX | โโ% | $133.37B | 30.3x |
| Bristol Myers Squibb โฆ | BMY | โโ% | $128.41B | 13.8x |
| Regeneron Pharmaceuticals, Inc. | REGN | โโ% | $81.13B | 18.7x |
| Sanofi | SNY | โโ% | $50.13B | -x |
| Teva Pharmaceutical Industries โฆ | TEVA | โโ% | $45.67B | 64.6x |
| Alnylam Pharmaceuticals, Inc. | ALNY | โโ% | $34.25B | -x |
| Alterity Therapeutics Ltd | ATHE | โโ% | $33.50B | -x |
| Royalty Pharma Plc | RPRX | โโ% | $33.47B | 41.1x |
| Takeda Pharmaceutical Co โฆ | TAK | โโ% | $30.01B | -x |
| Zoetis Inc. | ZTS | โโ% | $29.36B | 11.2x |
| Zai Lab Ltd | ZLAB | โโ% | $28.04B | -x |
| Roivant Sciences Ltd. | ROIV | โโ% | $25.86B | -x |
| Insmed Inc | INSM | โโ% | $25.73B | -x |
| Viatris Inc | VTRS | โโ% | $20.48B | -x |
| United Therapeutics Corp | UTHR | โโ% | $20.39B | 15.6x |
| Jazz Pharmaceuticals Plc | JAZZ | โโ% | $15.45B | 16.4x |
| Ascendis Pharma A/S | ASND | โโ% | $13.98B | -x |
| Bridgebio Pharma, Inc. | BBIO | โโ% | $12.82B | -x |
| Corcept Therapeutics Inc | CORT | โโ% | $12.55B | -x |
| Summit Therapeutics Inc. | SMMT | โโ% | $12.45B | -x |
| Hutchmed (China) Ltd | HCM | โโ% | $12.16B | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | โโ% | $11.93B | -x |
| Kiniksa Pharmaceuticals International, โฆ | KNSA | โโ% | $11.72B | -x |
| Biomarin Pharmaceutical Inc | BMRN | โโ% | $11.66B | -x |
| Elanco Animal Health โฆ | ELAN | โโ% | $11.15B | -x |
| Dr Reddys Laboratories โฆ | RDY | โโ% | $10.22B | -x |
| Axsome Therapeutics, Inc. | AXSM | โโ% | $10.22B | -x |
| Protagonist Therapeutics, Inc | PTGX | โโ% | $9.18B | -x |
| Cytokinetics Inc | CYTK | โโ% | $8.99B | -x |
| Praxis Precision Medicines, โฆ | PRAX | โโ% | $7.84B | -x |
| Structure Therapeutics Inc. | GPCR | โโ% | $7.69B | -x |
| Spyre Therapeutics, Inc. | SYRE | โโ% | $7.56B | -x |
| Abivax S.A. | ABVX | โโ% | $7.45B | -x |
| Ionis Pharmaceuticals Inc | IONS | โโ% | $7.40B | -x |
| Legend Biotech Corp | LEGN | โโ% | $7.07B | -x |
| Alkermes Plc. | ALKS | โโ% | $6.85B | -x |
| Rhythm Pharmaceuticals, Inc. | RYTM | โโ% | $6.79B | -x |
| Biolinerx Ltd. | BLRX | โโ% | $6.79B | -x |
| Belite Bio, Inc | BLTE | โโ% | $6.58B | -x |
| Amneal Pharmaceuticals, Inc. | AMRX | โโ% | $6.31B | -x |
| Liquidia Corp | LQDA | โโ% | $6.13B | -x |
| Ligand Pharmaceuticals Inc | LGND | โโ% | $6.01B | 30.5x |
| Mirum Pharmaceuticals, Inc. | MIRM | โโ% | $5.82B | -x |
| Cogent Biosciences, Inc. | COGT | โโ% | $5.61B | -x |
| Travere Therapeutics, Inc. | TVTX | โโ% | $5.60B | -x |
| Amarin Corp Plc\Uk | AMRN | โโ% | $5.54B | -x |
| Ptc Therapeutics, Inc. | PTCT | โโ% | $5.23B | -x |
| Erasca, Inc. | ERAS | โโ% | $4.98B | -x |
| Dianthus Therapeutics, Inc. โฆ | DNTH | โโ% | $4.95B | -x |
| Veradermics, Inc | MANE | โโ% | $4.87B | -x |
FAQ
-
Is Arrowhead Pharmaceuticals, Inc. a good stock to buy?
Our AI analyzes Arrowhead Pharmaceuticals, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
-
How accurate are Arrowhead Pharmaceuticals, Inc. predictions?
A per-ticker accuracy statistic for ARWR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
-
How often are forecasts updated?
Arrowhead Pharmaceuticals, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Sept. 25, 2026.
Ready to invest smarter?
Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Arrowhead Pharmaceuticals, Inc.?
View full institutional-grade analysis on Intratio โAI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.